GSK Confidential Information means GSK Data that (a) is marked or otherwise identified as “confidential” or with a similar designation, or (b) even if it is not marked or identified as “confidential,” a reasonable person would recognize as information that ought to be treated as confidential information, including information relating to the trade secrets such as know-how, formulae and processes, scientific research, clinical development, or business affairs of GSK; GSK Personal Information; all project and computer-related technical matters, including design/performance specifications, operating procedures, systems documentation, utility reference manuals, language reference manuals, third party software and documentation, financial information, inventions, contractual information (including pending deals), customer information such as patient and supplier lists, prices and costs, data related to regulatory submissions, and any other relevant information furnished to Supplier and Supplier Personnel by or on behalf of GSK under the Agreement. GSK Confidential Information shall not include: (i) information which at the time of disclosure or discovery is in the public domain; (ii) information which, after disclosure, becomes part of the public domain by publication or otherwise, except by breach of the Agreement; (iii) information which Supplier can establish by reasonable proof was in its possession at the time of disclosure by GSK and was not acquired, directly or indirectly, from GSK; or (iv) information which Supplier receives from a third party, provided, however, that such information was not obtained by said third party, directly or indirectly, from GSK and that said party has a right to disclose it. 2.6 GSK Data.
GSK Confidential Information means Confidential Information relating to or disclosed by GSK or its Affiliates and includes GSK Data and GSK Personal Information.
GSK Confidential Information means any and all information that is disclosed on or after the Effective Date by GSK or any of its Affiliates to Sirtris relating to targets for therapeutic applications in multiple categories, including but not limited to, neurology, neurodegenerative disease/movement disorders, metabolism, cardiovascular and ophthalmology.
Examples of GSK Confidential Information in a sentence
Access to GSK Confidential Information (whether remote or otherwise); must have been the subject of pre-engagement screening in accordance with Clause 20.5 and Schedule 1 of the GSK Standard Terms and Conditions as updated and/or revised by Appendix A (Pre-Engagement Screening).
Table 7.1 summarizes the versions that have been prepared and reviewed.
If the initial determination is that a significant and adverse impact will occur, attach documentation of appropriatemitigation.
Figure 3-8 displays the geographic distribution of the IRF beds per 100,000 beneficiaries in the U.S. in 2006.
Supplier will acquire knowledge of GSK Confidential Information (as defined below) in connection with its performance hereunder and agrees to keep such GSK Confidential Information in confidence during and following termination or expiration of this Agreement.
More Definitions of GSK Confidential Information
GSK Confidential Information will have the meaning set forth in Section 11.1.
GSK Confidential Information means all confidential business and technical communications, documents and other information, whether in written, oral or other form, which GSK or a GSK Affiliate furnishes or discloses to Prometheus or which Prometheus otherwise learns in connection with the negotiation or performance of this Agreement (whether relating to GSK, a GSK Affiliate or any Third Party for which GSK has an obligation of confidentiality). Prometheus agrees that the provisions of this Agreement shall apply to all GSK Confidential Information disclosed by GSK or a GSK Affiliate to Prometheus or learned by Prometheus prior to the Effective Date. Prometheus represents and warrants that prior to the Effective Date, it has not used or disclosed to any Third Party any GSK Confidential Information, except as would be permitted hereunder.
GSK Confidential Information means Confidential Information owned by GSK and/or its Affiliates or otherwise designated as GSK Confidential Information hereunder but shall not include Joint Confidential Information.
GSK Confidential Information means any confidential or proprietary information, including inventions, methods, plans, processes, specifications, Know-How, Trade Secrets, compounds, materials, Materials, GSK Data, business plans, business proposals, financial statements, cost information, Personal Information of GSK Personnel, software, models (including model parameters) and technical information, disclosed by or on behalf of GSK or any of its Affiliates to Tempus or any of its Affiliates or representatives or obtained from GSK or its Affiliates or their Personnel by Tempus or Tempus Personnel in connection with the performance of the Activities; provided, that “GSK Confidential Information” shall not include information which (i) at the time of disclosure or discovery is in the public domain; (ii) after disclosure, becomes part of the public domain by publication or otherwise, except by breach by Tempus or any of its Affiliates or representatives of the terms of this Agreement or a Task Order; (iii) Tempus can establish by reasonable proof was in its possession at the time of disclosure by GSK or its Affiliates and was not acquired, directly or indirectly, from GSK; (iv) Tempus receives from a third party that has the legal right to disclose such information, free of any confidentiality obligation; or (v) Tempus can establish by reasonable proof was independently developed by Tempus without any use of or reference to GSK Confidential Information. GSK Confidential Information includes the GSK Background Intellectual Property, GSK Arising IP, and all GSK Work Product.
GSK Confidential Information means all information relating to the biopharmaceutical manufacturing technologies employed by GSK and financial information provided by GSK, confidential business and technical communications, documents and other information, in each case, in any form (whether in written, oral, photographic, electronic, magnetic, computer or other form), including without limitation methods, techniques and processes, and technical and scientific data, unpublished findings, biological material, know how, specifications, patent applications, algorithms, programs, designs, drawings, formulae, engineering, manufacturing, marketing, financial and business plans and data, which GSK or a GSK Affiliate furnishes or discloses to DENDREON or which DENDREON otherwise learns in connection with the negotiation or performance of this Agreement (whether relating to GSK, a GSK Affiliate or any Third Party for which GSK has an obligation of confidentiality).
GSK Confidential Information means all information (including, without limitation, Study Protocols, case report forms, clinical data, other data, reports, specifications, computer programs or models and related documentation, know-how, trade secrets, including, without limitation, any technologies and know-how pertaining to GSK Assay(s) or business or research plans) of GSK or GSK’s Affiliates that are: (1) provided to RGI or RGI’s Affiliates in connection with this Master Agreement or a Task Order, or in connection with a request for proposals, proposals, or otherwise related to a project which potentially could be the subject of a Task Order, whether or not a Task Order is ever executed; or (2) created or developed by RGI, RGI’s Affiliates or a Third Party associated with RGI (including, without limitation, RGI’s employees, agents, or subcontractors), or by Study Investigators and staff, in connection with this Master Agreement or a Task Order. This Master Agreement and the terms and conditions herein shall be considered to be GSK Confidential Information.
GSK Confidential Information means all information (including, without limitation, study protocols, case report forms, clinical data, other data, reports, specifications, computer programs or models and related documentation, know-how, trade secrets, or business or research plans) of GSK or GSK’s Affiliates that are: (1) provided to Institution in connection with this Master Agreement, a Study Specific Agreement (as defined below), or a Study, or in connection with a planned Study which potentially could be the subject of a Study Specific Agreement, even without an executed Study Specific Agreement; (2) and subject to Institution’s publication rights under Section 8 below, Study data, results, or reports created by Institution, Investigators (as defined below), or Study Staff (as defined below) in connection with the Study (except for a Study subject’s medical records); and (3) cumulative Study data, results, and reports from all sites conducting the Study.